vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and AGIOS PHARMACEUTICALS, INC. (AGIO). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $11.9M, roughly 1.7× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -541.1%, a 532.3% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 13.3%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -34.9%).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
ACNT vs AGIO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $20.0M |
| Net Profit | $-1.0M | $-108.0M |
| Gross Margin | 14.6% | 90.6% |
| Operating Margin | -21.0% | -608.9% |
| Net Margin | -8.8% | -541.1% |
| Revenue YoY | 13.3% | 86.1% |
| Net Profit YoY | -1.2% | -11.9% |
| EPS (diluted) | $-0.11 | $-1.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | $20.0M | ||
| Q3 25 | $19.7M | $12.9M | ||
| Q2 25 | $18.7M | $12.5M | ||
| Q1 25 | $24.7M | $8.7M | ||
| Q4 24 | $10.5M | $10.7M | ||
| Q3 24 | $20.9M | $9.0M | ||
| Q2 24 | $21.5M | $8.6M | ||
| Q1 24 | $28.0M | $8.2M |
| Q4 25 | $-1.0M | $-108.0M | ||
| Q3 25 | $-2.1M | $-103.4M | ||
| Q2 25 | $6.3M | $-112.0M | ||
| Q1 25 | $-2.3M | $-89.3M | ||
| Q4 24 | $-1.0M | $-96.5M | ||
| Q3 24 | $-6.2M | $947.9M | ||
| Q2 24 | $-926.0K | $-96.1M | ||
| Q1 24 | $-5.5M | $-81.5M |
| Q4 25 | 14.6% | 90.6% | ||
| Q3 25 | 29.7% | 87.0% | ||
| Q2 25 | 26.1% | 86.3% | ||
| Q1 25 | 19.3% | 87.6% | ||
| Q4 24 | 24.3% | 88.3% | ||
| Q3 24 | 14.4% | 91.3% | ||
| Q2 24 | 13.1% | 82.6% | ||
| Q1 24 | 8.3% | 92.3% |
| Q4 25 | -21.0% | -608.9% | ||
| Q3 25 | -4.1% | -907.4% | ||
| Q2 25 | -14.4% | -1020.1% | ||
| Q1 25 | -4.2% | -1222.0% | ||
| Q4 24 | -25.4% | -1165.3% | ||
| Q3 24 | -9.4% | -1146.9% | ||
| Q2 24 | -8.6% | -1228.3% | ||
| Q1 24 | -15.5% | -1124.3% |
| Q4 25 | -8.8% | -541.1% | ||
| Q3 25 | -10.6% | -803.1% | ||
| Q2 25 | 33.7% | -899.4% | ||
| Q1 25 | -9.3% | -1023.3% | ||
| Q4 24 | -9.8% | -899.6% | ||
| Q3 24 | -29.5% | 10574.7% | ||
| Q2 24 | -4.3% | -1115.7% | ||
| Q1 24 | -19.7% | -995.8% |
| Q4 25 | $-0.11 | $-1.86 | ||
| Q3 25 | $-0.22 | $-1.78 | ||
| Q2 25 | $0.65 | $-1.93 | ||
| Q1 25 | $-0.23 | $-1.55 | ||
| Q4 24 | $-0.11 | $-1.44 | ||
| Q3 24 | $-0.61 | $16.22 | ||
| Q2 24 | $-0.09 | $-1.69 | ||
| Q1 24 | $-0.54 | $-1.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | $89.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.0M | $1.2B |
| Total Assets | $111.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | $89.1M | ||
| Q3 25 | $58.0M | $92.7M | ||
| Q2 25 | $60.5M | $80.9M | ||
| Q1 25 | $14.3M | $79.0M | ||
| Q4 24 | $16.1M | $76.2M | ||
| Q3 24 | $8.5M | $253.7M | ||
| Q2 24 | $3.6M | $84.5M | ||
| Q1 24 | $1.3M | $118.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.0M | $1.2B | ||
| Q3 25 | $87.1M | $1.3B | ||
| Q2 25 | $89.7M | $1.4B | ||
| Q1 25 | $91.2M | $1.5B | ||
| Q4 24 | $93.5M | $1.5B | ||
| Q3 24 | $94.7M | $1.6B | ||
| Q2 24 | $101.0M | $660.5M | ||
| Q1 24 | $102.0M | $743.9M |
| Q4 25 | $111.9M | $1.3B | ||
| Q3 25 | $119.9M | $1.4B | ||
| Q2 25 | $122.6M | $1.5B | ||
| Q1 25 | $152.5M | $1.6B | ||
| Q4 24 | $147.3M | $1.7B | ||
| Q3 24 | $148.6M | $1.8B | ||
| Q2 24 | $158.2M | $773.1M | ||
| Q1 24 | $161.0M | $849.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $-96.2M |
| Free Cash FlowOCF − Capex | $-196.0K | $-97.3M |
| FCF MarginFCF / Revenue | -1.7% | -487.5% |
| Capex IntensityCapex / Revenue | 3.9% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | $-377.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | $-96.2M | ||
| Q3 25 | $1.3M | $-88.2M | ||
| Q2 25 | $-1.4M | $-77.1M | ||
| Q1 25 | $-700.0K | $-111.5M | ||
| Q4 24 | $8.8M | $-133.2M | ||
| Q3 24 | $3.4M | $-84.2M | ||
| Q2 24 | $2.2M | $-72.6M | ||
| Q1 24 | $263.0K | $-99.9M |
| Q4 25 | $-196.0K | $-97.3M | ||
| Q3 25 | $695.0K | $-89.7M | ||
| Q2 25 | $-1.5M | $-78.0M | ||
| Q1 25 | $-1.0M | $-112.3M | ||
| Q4 24 | $8.4M | $-134.1M | ||
| Q3 24 | $3.1M | $-84.6M | ||
| Q2 24 | $1.9M | $-72.7M | ||
| Q1 24 | $25.0K | $-100.0M |
| Q4 25 | -1.7% | -487.5% | ||
| Q3 25 | 3.5% | -696.5% | ||
| Q2 25 | -8.3% | -626.2% | ||
| Q1 25 | -4.1% | -1286.4% | ||
| Q4 24 | 80.6% | -1250.1% | ||
| Q3 24 | 15.1% | -944.2% | ||
| Q2 24 | 9.1% | -844.4% | ||
| Q1 24 | 0.1% | -1221.2% |
| Q4 25 | 3.9% | 5.6% | ||
| Q3 25 | 3.1% | 12.1% | ||
| Q2 25 | 0.8% | 7.0% | ||
| Q1 25 | 1.3% | 8.8% | ||
| Q4 24 | 3.7% | 9.0% | ||
| Q3 24 | 1.3% | 4.7% | ||
| Q2 24 | 1.0% | 1.8% | ||
| Q1 24 | 0.9% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.09× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
AGIO
Segment breakdown not available.
